SELLAS Life Sciences Group Inc Sustainability Reports
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. Its product candidates include galinpepimut-S (GPS) and SLS009.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300VZIH50VYURLQ98
FIGI: BBG001T223C9
1 reports from 2020 to 2020